IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani.

Pitta, Maira G R; Romano, Audrey; Cabantous, Sandrine; Henri, Sandrine; Hammad, Awad; Kouriba, Bouréma; Argiro, Laurent; el Kheir, Musa; Bucheton, Bruno; Mary, Charles; El-Safi, Sayda Hassan; Dessein, Alain

Pitta, Maira G R; Romano, Audrey; Cabantous, Sandrine; Henri, Sandrine; Hammad, Awad; Kouriba, Bouréma; Argiro, Laurent; el Kheir, Musa; Bucheton, Bruno; Mary, Charles; El-Safi, Sayda Hassan; Dessein, Alain.

Affiliation

Pitta MG; INSERM, Unité 906, Marseille, France.

J Clin Invest ; 119(8): 2379-87, 2009 Aug.

Article in En | MEDLINE | ID: mdl-19620772

Subject(s)

Interleukin-17/physiology; Interleukins/physiology; Leishmaniasis, Visceral/immunology; Animals; Humans; Interleukin-1beta/biosynthesis; Interleukin-23/biosynthesis; Interleukin-6/biosynthesis; Leukocytes, Mononuclear/immunology; Th1 Cells/immunology; Th2 Cells/immunology; Interleukin-22

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Interleukins / Interleukin-17 / Leishmaniasis, Visceral Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Year: 2009 Type: Article

Fulltext

XML

PubMed Links

Search on Google